Big Data Probably Knows More About You Than Your Friends Do

Big Data Probably Knows More About You Than Your Friends Do

A representation of the digital lifestyle prevalent today that enables the collection of a wealth of data.

(© zapp2photo/Fotolia)


Keep Reading Keep Reading
Jennifer Miller
Jennifer E. Miller, PhD, is an Assistant Professor in NYU School of Medicine and President of the nonprofit Bioethics International. She is also the Creator of the Good Pharma Scorecard, an index that ranks new drugs and pharmaceutical companies on their ethics performance. She is also a member of The World Economic Forum and serves on NYU’s Pharmacy and Therapeutics Committee and stem cell research oversight board. Prior to joining NYU’s faculty, Dr. Miller was based at Duke University and Harvard University and served on the CDC Task Force for Pediatric Emergency Mass Critical Care, the AMA Advanced Disaster Life Support Education Consortium, as a consultant to the UN Economic and Social Council, and on the PCORI-NIH Collaboratory. A prolific writer, Dr. Miller has authored over 40 publications, including for Nature Medicine, Health Affairs, and The Scientist. She was a Fox News pundit from 2009 to 2012 and remains a commentator on CBS news, Wall Street Journal, Washington Post, Bloomberg News, Forbes, Dr. Oz and NPR.
A new type of cancer therapy is shrinking deadly brain tumors with just one treatment

MRI scans after a new kind of immunotherapy for brain cancer show remarkable progress in one patient just days after the first treatment.

Mass General Hospital

Few cancers are deadlier than glioblastomas—aggressive and lethal tumors that originate in the brain or spinal cord. Five years after diagnosis, less than five percent of glioblastoma patients are still alive—and more often, glioblastoma patients live just 14 months on average after receiving a diagnosis.

But an ongoing clinical trial at Mass General Cancer Center is giving new hope to glioblastoma patients and their families. The trial, called INCIPIENT, is meant to evaluate the effects of a special type of immune cell, called CAR-T cells, on patients with recurrent glioblastoma.

Keep Reading Keep Reading
Sarah Watts

Sarah Watts is a health and science writer based in Chicago.

Artificial Intelligence is getting better than humans at detecting breast cancer

A recent study in The Lancet Oncology showed that AI found 20 percent more cancers on mammogram screens than radiologists alone.

The Lancet Oncology

Since the early 2000s, AI systems have eliminated more than 1.7 million jobs, and that number will only increase as AI improves. Some research estimates that by 2025, AI will eliminate more than 85 million jobs.

But for all the talk about job security, AI is also proving to be a powerful tool in healthcare—specifically, cancer detection. One recently published study has shown that, remarkably, artificial intelligence was able to detect 20 percent more cancers in imaging scans than radiologists alone.

Keep Reading Keep Reading
Sarah Watts

Sarah Watts is a health and science writer based in Chicago.